Bristol-Myers Squibb Forecast, price target & analysts
Bristol-Myers Squibb Target price 2026 - Analyst rating & recommendation
Bristol-Myers Squibb Classifications & Recommendation
Bristol-Myers Squibb Price Target
| Target Price | $69.36 |
| Price | $62.84 |
| Potential |
10.38%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Bristol-Myers Squibb 2027 .
The average Bristol-Myers Squibb target price is $69.36.
This is
10.38%
register free of charge
$84.00
33.67%
register free of charge
$40.40
35.71%
register free of charge
|
|
| A rating was issued by 35 analysts: 15 Analysts recommend Bristol-Myers Squibb to buy, 18 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bristol-Myers Squibb stock has an average upside potential 2027 of
10.38%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 48.19 | 50.14 |
| 0.22% | 4.04% | |
| EBITDA Margin | 42.12% | 38.04% |
| 0.35% | 9.69% | |
| Net Margin | 14.64% | 28.41% |
| 179.01% | 94.10% |
30 Analysts have issued a sales forecast Bristol-Myers Squibb 2026 . The average Bristol-Myers Squibb sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Bristol-Myers Squibb EBITDA forecast 2026. The average Bristol-Myers Squibb EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
31 Bristol-Myers Squibb Analysts have issued a net profit forecast 2026. The average Bristol-Myers Squibb net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.46 | 6.97 |
| 178.46% | 101.45% | |
| P/E | 9.01 | |
| EV/Sales | 3.20 |
31 Analysts have issued a Bristol-Myers Squibb forecast for earnings per share. The average Bristol-Myers Squibb EPS is
This results in the following potential growth metrics and future valuations:
Bristol-Myers Squibb...
Current Bristol-Myers Squibb Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HSBC |
Locked
➜
Locked
|
Locked | Sep 10 2026 |
| Argus Research |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
HSBC:
Locked
➜
Locked
|
Sep 10 2026 |
|
Locked
Argus Research:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 31 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
